Dr Matthew Boente MD
17 SlideShares
Personal Information
Webseite
drmatthewboentemd.home.blog/
Info
Dr. Matthew Boente MD served as Chief of Gynecologic Oncology at Fox Chase Cancer Center, Medical Director, Division of Gynecologic Oncology at Methodist Hospital, Director, Division of Gynecologic Oncology at University of Minnesota’s Department of Obstetrics, Gynecology & Women’s Health, and Principal Investigator at Minnesota Oncology. Dr. Boente’s most recent posting was as Medical Director for U.S. Medical Affairs, Gynecologic Oncology at Genentech Inc. in San Francisco, where he led a large global cross-functional team responsible for the FDA approval of bevacizumab with chemotherapy in front line ovarian cancer.
Tags
dr matthew boente md ovarian cancer chronic traumatic encephalopathy cte obstetrics gynecology medicine brain injuries healthcare health care healthcare system medical professional global health threats coronavirus covid-19 degree in medicine gynecologist obstetrician chemotherapy fda breast and ovarian cancer patient associate professor gynecologic oncology dr. matthew boente md chronic traumatic encephalopathy: physician living patient diagnosis of cte sports brain injury players football cte risk brain disease doctor
Mehr anzeigen

Präsentationen

(2)

Dr Matthew Boente MD

Vor 3 Jahren • 10 Aufrufe

Dr Matthew Boente MD

Vor 3 Jahren • 23 Aufrufe

Dokumente

(15)
Alle anzeigen

Ovarian Cancer

Vor 4 Jahren • 10 Aufrufe

Can Science Solve Football's Concussion Crisis?

Vor 4 Jahren • 14 Aufrufe

Seven Ways To Reduce Risk of Traumatic Brain Injury In Sports

Vor 4 Jahren • 6 Aufrufe

Former NFL player confirmed as 1st diagnosis of CTE in living patient

Vor 4 Jahren • 12 Aufrufe

What Is CTE?

Vor 4 Jahren • 12 Aufrufe

Dr Matthew Boente MD

Vor 3 Jahren • 7 Aufrufe

FDA approves bevacizumab in combination with chemotherapy for ovarian cancer

Vor 3 Jahren • 12 Aufrufe

Joe Biden's Health Care Plan Would Fix the Individual Health Insurance System

Vor 3 Jahren • 69 Aufrufe

THE BIDEN PLAN TO COMBAT CORONAVIRUS (COVID-19) AND PREPARE FOR FUTURE GLOBAL HEALTH THREATS

Vor 3 Jahren • 72 Aufrufe

FDA approves bevacizumab in combination with chemotherapy for ovarian cancer

Vor 3 Jahren • 10 Aufrufe

FDA Approves Bevacizumab in Combination With Chemotherapy for Ovarian Cancer

Vor 3 Jahren • 13 Aufrufe

FDA Approves Genentech’s Avastin® (Bevacizumab) Plus Chemotherapy as a Treatment for Women with Advanced Ovarian Cancer Following Initial Surgery

Vor 3 Jahren • 45 Aufrufe

Joe Biden's Health Care Plan Would Fix the Individual Health Insurance System

Vor 3 Jahren • 26 Aufrufe

HEALTHCARE:COMMUNITIESOF COLOR

Vor 3 Jahren • 20 Aufrufe

THE BIDEN PLAN TO PROTECT & BUILD ON THE AFFORDABLE CARE ACT

Vor 3 Jahren • 29 Aufrufe
Personal Information
Webseite
drmatthewboentemd.home.blog/
Info
Dr. Matthew Boente MD served as Chief of Gynecologic Oncology at Fox Chase Cancer Center, Medical Director, Division of Gynecologic Oncology at Methodist Hospital, Director, Division of Gynecologic Oncology at University of Minnesota’s Department of Obstetrics, Gynecology & Women’s Health, and Principal Investigator at Minnesota Oncology. Dr. Boente’s most recent posting was as Medical Director for U.S. Medical Affairs, Gynecologic Oncology at Genentech Inc. in San Francisco, where he led a large global cross-functional team responsible for the FDA approval of bevacizumab with chemotherapy in front line ovarian cancer.
Tags
dr matthew boente md ovarian cancer chronic traumatic encephalopathy cte obstetrics gynecology medicine brain injuries healthcare health care healthcare system medical professional global health threats coronavirus covid-19 degree in medicine gynecologist obstetrician chemotherapy fda breast and ovarian cancer patient associate professor gynecologic oncology dr. matthew boente md chronic traumatic encephalopathy: physician living patient diagnosis of cte sports brain injury players football cte risk brain disease doctor
Mehr anzeigen